Blocking adenosine production with CPI-006 enhanced immune-cell mediated tumor killing (220pM) and reversed suppression of T cell proliferation (EC50, 70nM) and IFNγ secretion (EC50, 66nM). This evidence concerns the gene IFNG and neoplasm.